Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 25944-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- PTPN13 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated PTPN13 antibody (Cat. #25944-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, WB, ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Distinctive genes and signaling pathways associated with type 2 diabetes-related periodontitis: Preliminary study.
PTPN13 Participates in the Regulation of Epithelial-Mesenchymal Transition and Platinum Sensitivity in High-Grade Serous Ovarian Carcinoma Cells.
Direct conversion of human umbilical cord mesenchymal stem cells into retinal pigment epithelial cells for treatment of retinal degeneration.
Protein tyrosine phosphatase PTPL1 suppresses lung cancer through Src/ERK/YAP1 signaling.
Cancer-derived IgG involved in cisplatin resistance through PTP-BAS/Src/PDK1/AKT signaling pathway.
Duarte PM, Gurgel BCV, Miranda TS, Sardenberg J, Gu T, Aukhil I
PloS one 2024;19(1):e0296925
PloS one 2024;19(1):e0296925
PTPN13 Participates in the Regulation of Epithelial-Mesenchymal Transition and Platinum Sensitivity in High-Grade Serous Ovarian Carcinoma Cells.
Aptecar L, Puech C, Lopez-Crapez E, Peter M, Coopman P, D'Hondt V, Freiss G
International journal of molecular sciences 2023 Oct 21;24(20)
International journal of molecular sciences 2023 Oct 21;24(20)
Direct conversion of human umbilical cord mesenchymal stem cells into retinal pigment epithelial cells for treatment of retinal degeneration.
Zhu X, Chen Z, Wang L, Ou Q, Feng Z, Xiao H, Shen Q, Li Y, Jin C, Xu JY, Gao F, Wang J, Zhang J, Zhang J, Xu Z, Xu GT, Lu L, Tian H
Cell death & disease 2022 Sep 12;13(9):785
Cell death & disease 2022 Sep 12;13(9):785
Protein tyrosine phosphatase PTPL1 suppresses lung cancer through Src/ERK/YAP1 signaling.
Wang J, Li S, Zhang X, Zhu N, Yiminniyaze R, Dong L, Li C, Gulinuer W, Xia J, Li J, Zhou D, Liu X, Zhang Y, Zhang Y, Li S
Thoracic cancer 2022 Nov;13(21):3042-3051
Thoracic cancer 2022 Nov;13(21):3042-3051
Cancer-derived IgG involved in cisplatin resistance through PTP-BAS/Src/PDK1/AKT signaling pathway.
Wang LM, Gan YH
Oral diseases 2021 Apr;27(3):464-474
Oral diseases 2021 Apr;27(3):464-474
No comments: Submit comment
No validations: Submit validation data